Outcome measures in clinical trials for multiple sclerosis

CEP van Munster, BMJ Uitdehaag - CNS drugs, 2017 - Springer
Due to the heterogeneous nature of the disease, it is a challenge to capture disease activity
of multiple sclerosis (MS) in a reliable and valid way. Therefore, it can be difficult to assess …

Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review

L Lakin, BE Davis, CC Binns, KM Currie… - Neurology and therapy, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …

Vision and vision-related outcome measures in multiple sclerosis

LJ Balcer, DH Miller, SC Reingold, JA Cohen - Brain, 2015 - academic.oup.com
Visual impairment is a key manifestation of multiple sclerosis. Acute optic neuritis is a
common, often presenting manifestation, but visual deficits and structural loss of retinal …

Ganglion cell loss in relation to visual disability in multiple sclerosis

SD Walter, H Ishikawa, KM Galetta, RE Sakai, DJ Feller… - Ophthalmology, 2012 - Elsevier
PURPOSE: We used high-resolution spectral-domain optical coherence tomography (SD-
OCT) with retinal segmentation to determine how ganglion cell loss relates to history of …

Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis

LS Talman, ER Bisker, DJ Sackel… - Annals of …, 2010 - Wiley Online Library
Objective Cross‐sectional studies of optical coherence tomography (OCT) show that retinal
nerve fiber layer (RNFL) thickness is reduced in multiple sclerosis (MS) and correlates with …

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis

LJ Balcer, J Raynowska, R Nolan… - Multiple Sclerosis …, 2017 - journals.sagepub.com
Low-contrast letter acuity (LCLA) has emerged as the leading outcome measure to assess
visual disability in multiple sclerosis (MS) research. As visual dysfunction is one of the most …

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study

RC Nolan‐Kenney, M Liu, O Akhand… - Annals of …, 2019 - Wiley Online Library
Objective To determine the optimal thresholds for intereye differences in retinal nerve fiber
and ganglion cell+ inner plexiform layer thicknesses for identifying unilateral optic nerve …

Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders

JS Graves, FC Oertel, A Van der Walt… - Neurology …, 2021 - AAN Enterprises
The visual system offers unparalleled precision in the assessment of neuroaxonal damage.
With the majority of patients with multiple sclerosis (MS) experiencing afferent and efferent …

Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis

E Schneider, H Zimmermann, T Oberwahrenbrock… - PloS one, 2013 - journals.plos.org
Background Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS)
are difficult to differentiate solely on clinical grounds. Optical coherence tomography (OCT) …

Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection

RE Sakai, DJ Feller, KM Galetta… - Journal of Neuro …, 2011 - journals.lww.com
Visual dysfunction is one of the most common clinical manifestations of multiple sclerosis
(MS). Just over a decade ago, MS clincial trials did not include visual outcomes, but experts …